Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Brendel

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Nature|July 8, 2026
Non-genotoxic transplantation and in vivo selection through epitope editingGabriele Casirati, Andrea Cosentino, Marta Freschi, et al.
Nature Communications|September 20, 2023
Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sicklingDaniel C De Souza, Nicolas Hebert, Erica B Esrick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2014
Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorKurt Schönfeld, Christiane Sahm, Congcong Zhang, et al.
The New England Journal of Medicine|December 7, 2020
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell DiseaseErica B Esrick, Leslie E Lehmann, Alessandra Biffi, et al.
Nature Medicine|March 27, 2019
Highly efficient therapeutic gene editing of human hematopoietic stem cellsYuxuan Wu, Jing Zeng, Benjamin P Roscoe, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2024
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytesRoland Windisch, Sarah Soliman, Adrian Hoffmann, et al.
Human Gene Therapy. Clinical Development|July 13, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous diseaseStefan Stein, Simone Scholz, Joachim Schwäble, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Gene editing without <i>ex vivo</i> culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Cell Stem Cell|December 13, 2024
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Nature Communications|February 27, 2021
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndromeAlyssa L Kennedy, Kasiani C Myers, James Bowman, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Nature|July 8, 2026
Non-genotoxic transplantation and in vivo selection through epitope editingGabriele Casirati, Andrea Cosentino, Marta Freschi, et al.
Nature Communications|September 20, 2023
Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sicklingDaniel C De Souza, Nicolas Hebert, Erica B Esrick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2014
Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorKurt Schönfeld, Christiane Sahm, Congcong Zhang, et al.
The New England Journal of Medicine|December 7, 2020
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell DiseaseErica B Esrick, Leslie E Lehmann, Alessandra Biffi, et al.
Nature Medicine|March 27, 2019
Highly efficient therapeutic gene editing of human hematopoietic stem cellsYuxuan Wu, Jing Zeng, Benjamin P Roscoe, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2024
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytesRoland Windisch, Sarah Soliman, Adrian Hoffmann, et al.
Human Gene Therapy. Clinical Development|July 13, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous diseaseStefan Stein, Simone Scholz, Joachim Schwäble, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Gene editing without <i>ex vivo</i> culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Cell Stem Cell|December 13, 2024
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Nature Communications|February 27, 2021
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndromeAlyssa L Kennedy, Kasiani C Myers, James Bowman, et al.
Pageof 6